Technology | 2018.10.30
Catalent to Lead Debate on Developability Classification System at AAPS
Catalent Pharma Solutions (booth 1727), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will moderate multiple educational seminars and debate the effectiveness of the Developability Classification System (DCS), at the upcoming American Association of Pharmaceutical Scientists (AAPS) annual meeting and exposition being held at the Walter E. Washington Convention Center, Washington D.C., from November 4 – 7, 2018.
(PRWeb October 30, 2018)
Read the full story at https://www.prweb.com/releases/catalent_to_lead_debate_on_developability_classification_system_at_aaps/prweb15875411.htm
For more information, please visit
https://www.prweb.com/releases/catalent_[...]stem_at_aaps/prweb15875411.htm
